Zhang Sisi, Xiao Hui, Li Ning
Analytical Chemistry, Regeneron Pharmaceuticals, Tarrytown, NY, United States.
Analytical Chemistry, Regeneron Pharmaceuticals, Tarrytown, NY, United States.
J Pharm Sci. 2021 Dec;110(12):3866-3873. doi: 10.1016/j.xphs.2021.09.001. Epub 2021 Sep 4.
Polysorbates (PS) are surfactants commonly added in biologics formulations that can protect proteins from denaturation and aggregation. However, decreases in polysorbate 20 (PS20) content have been observed in some monoclonal antibody formulations, causing the formation of visible and/or subvisible particles that ultimately compromise the quality and stability of the therapeutic protein products. It was determined that the particles are mainly composed of free fatty acid, suggesting enzymatic hydrolysis of PS is responsible for the degradation of PS. Enrichment of host cell proteins (HCPs) by immunoprecipitation followed by shotgun proteomics have been utilized to identify the HCPs that can hydrolyze PS20. One HCP, sialate O-acetylesterase (SIAE), demonstrated strong enzymatic activity for PS20 degradation even at low concentration (<5 ppm level). Incubation of recombinant SIAE with PS20 resulted in a unique degradation pattern where the hydrolysis of monoester with short fatty acid chain (C12, C14) was observed but not the monoester with long fatty acid chain (C16, C18) or higher-order esters. SIAE was detected and quantitated in several formulated mAbs, and the amount of SIAE was positively correlated to PS20 degradation in these mAbs during incubation. Additional experiments also showed that when SIAE was depleted, PS20 degradation was diminished, suggesting a causality between SIAE and PS20 degradation. The lipase activity of SIAE is specific to PS20, but not to PS 80 (PS80), which contains monoesters with long chain fatty acid (C18) and higher-order esters. The specific esterase activity of SIAE on PS20 suggests a possible solution of using PS80 over PS20 to eliminate surfactant degradation in mAb products.
聚山梨酯(PS)是生物制剂配方中常用的表面活性剂,可保护蛋白质免于变性和聚集。然而,在一些单克隆抗体制剂中观察到聚山梨酯20(PS20)含量下降,导致形成可见和/或亚可见颗粒,最终影响治疗性蛋白质产品的质量和稳定性。已确定这些颗粒主要由游离脂肪酸组成,这表明PS的酶促水解是PS降解的原因。通过免疫沉淀富集宿主细胞蛋白(HCP),然后进行鸟枪法蛋白质组学分析,以鉴定能够水解PS20的HCP。一种HCP,唾液酸O-乙酰酯酶(SIAE),即使在低浓度(<5 ppm水平)下也表现出对PS20降解的强酶活性。重组SIAE与PS20孵育产生了独特的降解模式,其中观察到短脂肪酸链(C12、C14)单酯的水解,但长脂肪酸链(C16、C18)单酯或高阶酯未被水解。在几种配制的单克隆抗体中检测并定量了SIAE,并且在孵育期间这些单克隆抗体中SIAE的量与PS20降解呈正相关。额外的实验还表明,当SIAE被去除时,PS20降解减少,这表明SIAE与PS20降解之间存在因果关系。SIAE的脂肪酶活性对PS20具有特异性,但对PS 80(PS80)不具有特异性,PS80含有长链脂肪酸(C18)单酯和高阶酯。SIAE对PS20的特异性酯酶活性表明,在单克隆抗体产品中使用PS80而非PS20可能是消除表面活性剂降解的一种解决方案。